Detalles de la búsqueda
1.
Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer.
Int J Hyperthermia
; 40(1): 2157498, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755433
2.
DPPG2-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment in vivo.
Int J Hyperthermia
; 38(1): 1415-1424, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581259
3.
The conundrum of recurrent low-grade tumours: to treat or to observe?
Curr Opin Urol
; 28(6): 557-562, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30239413
4.
The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial.
Urol Oncol
; 40(7): 344.e1-344.e9, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35431132
5.
Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer.
Cancers (Basel)
; 13(3)2021 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33498535
6.
DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer.
Int J Nanomedicine
; 16: 75-88, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33447028
Resultados
1 -
6
de 6
1
Próxima >
>>